On June 8, Mao Qun'an, a spokesperson of the National Health and Family Planning Commission, said today that there are still some dilemmas in the social and medical institutions, and that there is still room for improvement in medical quality and social credibility. In the next step, we must actively guide the social medical institutions to follow the development path of connotation construction, and not to expand the scale one-sidedly. The National Health and Family Planning Commission held a regular press conference today. At the press conference, a reporter asked about the development of private hospitals and whether the state has new policy support and guidance. Mao Qun'an introduced that as of the end of 2015, China's private hospitals reached 14,500, accounting for 52.7% of the total number of hospitals nationwide, and this figure increased by 106% compared with 2010. The number of beds in private hospitals reached 1.034 million, accounting for 19.4% of the total number of hospital beds, an increase of 161% over 2010. It should be said that the development is still very fast, and the number of medical treatments, including medical personnel, is increasing. Mao Qun'an went on to say that in recent years, some measures have been taken to encourage the society to run medical treatments: First, open regional medical resource planning, reserve space for social medical development, and optimize the allocation of medical and health resources. The second is to regulate the approval of the establishment of medical institutions. We will implement the reform of the first license and the reform, and set up the approval process to provide a fair development space for the medical practitioners. The third is to promote the doctor's multi-point practice. The fourth is to reduce the restrictions on operational approval. For the application of the configuration of social medical institutions, the qualifications and technical capabilities of the personnel should be evaluated to ensure the relevant indicators of medical quality and safety, and the requirements for the evaluation indicators of the size of the bed and the number of emergency rooms should be appropriately reduced. The fifth is to strengthen the support of financial funds. Sixth is included in the scope of medical insurance. We must continue to improve the regulatory mechanism and create a good social atmosphere to encourage the healthy development of social medical institutions. Mao Qun'an also mentioned that social medical institutions still have some difficulties in terms of talents and technical strength, and there is still room for improvement in medical quality and social credibility. In the next step, we will continue to actively promote social medical institutions in accordance with the relevant policies of the state, such as strengthening the setting of plans and guiding the orderly development of medical institutions. Guide the social medical institutions to take a differentiated development path, and form a complementary and benign and orderly market competition pattern with public hospitals. Encourage social doctors to organize new and urgently needed health services, including aged care, day care, and hospice care. Mao Qun'an also said that we must actively guide the social medical institutions to follow the development path of connotation construction, and not to expand the scale unilaterally. Further strengthen the supervision of the whole industry, resolutely punish and crack down on illegal and illegal behaviors and acts that harm the interests of the people. On the basis of simple administration and decentralization, we will further optimize services, promote the reform of the administrative examination and approval system, transform government functions, strengthen supervision and guidance, and, in accordance with the requirements of the State Council, put together, control, and combine services, and take measures to promote the benign nature of social medical treatment. development of. Tetanus Vaccine,Hepatitis B Vaccine For Adults,Tetanus Booster,Td Vaccine FOSHAN PHARMA CO., LTD. , https://www.fs-pharma.com